title: Safe Use of Therapeutic-Dose Oral Isotretinoin in Patients With a History of Pseudotumor Cerebri.
authors.affiliation: Department of Dermatology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
authors.forename: Suzanne J
authors.initials: SJ
authors.lastname: Tintle
authors.affiliation: Department of Dermatology, University of Alabama, Birmingham.
authors.forename: Julie C
authors.initials: JC
authors.lastname: Harper
authors.affiliation: Department of Dermatology, Jefferson Medical College, Philadelphia, Pennsylvania.
authors.forename: Guy F
authors.initials: GF
authors.lastname: Webster
authors.affiliation: Couture Dermatology and Plastic Surgery, Las Vegas, Nevada.
authors.forename: Grace K
authors.initials: GK
authors.lastname: Kim
authors.affiliation: Department of Dermatology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
authors.forename: Diane M
authors.initials: DM
authors.lastname: Thiboutot
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000009:adverse effects* / Q000627:therapeutic use*; D008911:Minocycline / Q000009:adverse effects* / Q000627:therapeutic use*; D011559:Pseudotumor Cerebri / Q000139:chemically induced*; D012008:Recurrence
chemical_list: D015474:Isotretinoin; D008911:Minocycline